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Abnormal Thin Filament Calcium Binding Associated with Cardiac Mus-
cle Diseases Can be Corrected Through TnC Mutagenesis
Bin Liu1, Ryan S. Lee1, Jack A. Rall1, Svetlana B. Tikunova2,
Jonathan P. Davis1.
1The Ohio State University, Columbus, OH, USA, 2University of Houston,
Houston, TX, USA.
The Ca2þ sensitivity of cardiac muscle force development can be adversely al-
tered during disease. Since troponin C (TnC) is the Ca2þ sensor for muscle con-
traction, TnC’s Ca2þ binding properties may be affected by the disease related
protein modifications. To test this hypothesis, a fluorescent TnC was utilized
to measure the Ca2þ binding sensitivity of TnC in the physiologically relevant
biochemical model system of reconstituted thin filaments. Consistent with the
pathophysiology, the inherited restrictive cardiomyopathy (RCM) mutation
TnI R192H and ischemia induced truncation of TnI (residues 1-192) increased
TnC’s Ca2þ binding sensitivity ~3 fold and ~7 fold, respectively; while the di-
lated cardiomyopathy (DCM) mutation TnT deltaK210 decreased TnC’s Ca2þ
binding sensitivity ~ 3 fold. Since the symptoms of the diseases may be caused
by the abnormal Ca2þ binding, correcting the Ca2þ binding might improve car-
diac function. To achieve this goal, we have engineered TnC constructs with
a wide, yet adjustable, range of Ca2þ binding sensitivities by modulating the neg-
atively charged residues in the Ca2þ chelating loop and/or by replacing key hy-
drophobic amino acids in the regulatory domain of TnC with polar Gln. We were
able to correct both the increased and decreased thin filament Ca2þ sensitivities
caused by the disease associated proteins via replacing the wild type TnC with
specifically engineered TnC constructs. Additionally, engineered TnC con-
structs can correct the disease related abnormal Ca2þ sensitivity of the acto-my-
osin ATPase assay and the force-pCa relationship in skinned trabeculae. This
study can potentially lead to a novel therapeutic strategy for treating cardiac
muscle diseases.
1842-Pos
Sarcomere Length Dependent Contractile Activation is Reduced in Rat
Trabeculae Exchanged with cTn Containing the L48Q cTnC Variant Inde-
pendently of Strong Binding Cross-Bridges
F. Steven Korte, Erik R. Feest, Maria V. Razumova, Michael Regnier.
University of Washington, Seattle, WA, USA.
Calcium sensitivity of the force-pCa relationship depends strongly on sarco-
mere length (SL) in cardiac muscle. It can also be influenced by maneuvers
that alter the distribution of cross-bridges within the cross-bridge cycle. We
have demonstrated that cardiac trabeculae have left-shifted and virtually elim-
inated SL dependence of force-pCa relationship following passive exchange
with cTn containing a mutant (L48Q) cTnC (with enhanced TnC-TnI interac-
tion). Here we designed experiments to investigate the importance of strongly
bound crossbridges and lattice spacing in modulating the force-pCa relation-
ship of WT and L48Q cTnC-cTn exchanged trabeculae. Using 3% dextran at
SL ¼ 2.0 mm to osmotically compress preparations to widths ~SL ¼ 2.3 mm,
we observed increased maximal force but not increased pCa50 in L48Q
cTnC-cTn exchanged trabeculae. Conversely, crossbridge inhibition with of
2,3-butanedione monoxime (BDM, 7 mM) at SL 2.3 mm decreased maximal
force and Ca2þ sensitivity in native and WT-cTn exchanged trabeculae to
levels measured at ~SL ¼ 2.0 mm. L48QcTnC-cTn exchanged preparations
treated with BDM also decreased maximal force to that seen at SL ¼ 2.0 mm,
but demonstrated no shift in Ca2þ sensitivity. This result is similar to decrease
in maximal force but no shift in Ca2þ sensitivity for L48Q cTnC-cTn ex-
changed preparations at SL 2.0 vs. 2.3 mm. The combined results further sup-
port the idea that L48Q cTnC confers crossbridge independence on thin fila-
ment activation. It may also imply that native thin filaments are dependent
on strong crossbridge binding for full activation because of relatively weak
cTnC-cTnI interaction. Finally, the relative strength of cTnC-cTnI interaction
may be an important determinant in length dependent activation of cardiac
muscle. Support provided by NIH HL65497 (MR) and T32 HL07828 (FSK).
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Engineering Troponin C to Improve Cardiomyocyte Contraction and
Relaxation Following Myocardial Infarction
Kate O. Buckley.
University of Washington, Seattle, WA, USA.
Gene based therapies targeting cardiac myofilaments offer a novel way to halt
or even reverse cardiac dysfunction following infarction by enhancing contrac-
tility of the heart. Experiments here were designed to test the ability of an en-
gineered troponin C (L48Q), with increased Ca2þ binding affinity to abrogate
contractile deficits of isolated adult rat cardiomyocytes from rat hearts infarctedby permanent ligation of the left descending coronary artery. After 4 weeks car-
diomyocytes from these and sham-operated, non-infarcted hearts were cultured
and incubated with adenoviral constructs containing cDNA for either GFP þ
WT cTnC or GFPþ L48Q cTnC. After 48-72 hours, stimulated cardiomyocyte
contraction and relaxation were measured using video microscopy (IonOptix).
In a sub-set of cardiomyocytes intracellular Ca2þ transients were measured fol-
lowing incubation with Fura-2. Myocardial infarction resulted in decreased ex-
tent (8.6 þ/- 1.0 %) and velocity of shortening (93.4 þ/- 13.0 mm/s) and relax-
ation velocity (51.3þ/- 6.4 mm/s), compared to control myocytes (12.1þ/- 2.4 %
and 147.3 þ/- 16.7 mm/s and 118.8 þ/- 16.3 mm/s, respectively). Expression of
L48Q cTnC in cardiomyocytes from infarcted hearts increased fractional short-
ening, shortening velocity, and relaxation velocity to near control values of
10.9 þ/- 1.3 % and 165.0 þ/- 23.6 mm/s and 141.7 þ/- 32.2 mm/s, respectively.
Interestingly, the peak Ca2þ transient amplitude was increased in cardiomyo-
cytes from infarcted hearts, from 9.9 þ/- 0.5 % in control cells to 23.0 þ/-
2.69 % in cells from infarcted hearts, which was also restored to near control
values with L48Q cTnC transfection to 11.9 þ/- 0.8 %. These results suggest
that targeted expression of L48Q cTnC may improve myocardial function in
infarcted hearts by reversing contractile dysfunction and improving sensitivity
to intracellular Ca2þ. Funding provided by NIH_HL091368 (MR, CEM),
AHA_T32 HL07828 (FSK).
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Calcium Sensitivity, Force Frequency Relation and Cardiac Troponin I:
Critical Role of PKA and PKC Phosphorylation Sites
Genaro A. Ramirez-Correa, Sonia Cortassa, Brian Stanley, Wei Dong Gao,
Anne M. Murphy.
Johns Hopkins School of Medicine, Baltimore, MD, USA.
Transgenic models with mutants of cardiac troponin I, cTnI-PKA S22,23D
(cTnIDD22,23) or cTnI-PKC S22A,S23D,S42,S44D (cTnI PKA/PKC) dis-
played differential force-frequency relationships (FFR) in vivo. We hypothe-
sized that these cTnI phospho-mimics would impact cardiac muscle force de-
velopment and Ca2þ sensitivity in opposite directions in a rate dependent
fashion. Our study shows that cTnIDD22,23 increases (while cTnI PKA/PKC de-
creases) its ability to generate normal force per unit of [Ca2þ]i when stimula-
tion frequency increases. Force-[Ca2þ]I hysteresis-loops revealed that
cTnIDD22,23 shows an increased calcium sensitivity in the activation phase
of force-[Ca2þ]i loops at 1 to 4 Hz when compared to NTG (Figure1E). An in-
tegrated computational model that encompasses electrophysiology, Ca2þ dy-
namics, contractile and mitochondrial activity (ECME model) indicates that
these cTnI mutants might change
the association-dissociation constants
for Ca2þ binding, both the low- and/
or high-affinity binding sites, of tro-
ponin complex. Our data indicate
that cTnI phosphorylation at PKA
sites is a crucial mediator of the
FFR by increasing the frequency-de-
pendent myofilament sensitivity;
which might be achieved by adaptive
changes on association-dissociation
constants for Ca2þ binding of the tro-
ponin complex.1845-Pos
Impact of Ischemia/Reperfusion Associated TnI Degradation on Cross-
Bridge Dynamics in Skinned Rat Cardiac Trabeculae
Kittipong Tachampa1,2, Helen Wang1, Pieter P. de Tombe1.
1Loyola University Chicago, Maywood, IL, USA, 2Chulalongkorn
University, Bangkok, Thailand.
Proteolytic degradation of Troponin I (cTnI) may be the cause for the depressed
contractility that is seen in myocardial stunning. Here, we studied the impact of
a proteolytic fragment cTnI63-193 (identified by McDonough et al, 1999) on
cross-bridge cycling dynamics in isolated myocardium. Murine cTnI63-193 mu-
tant, as well as wild type cTnC and cTnT, were expressed in E.coli. Next, FPLC
purified Troponin (cTn) complex containing either wild type cTnI or cTnI63-193
was exchanged for endogenous cTn in skinned rat cardiac trabeculae; Western
blot analysis confirmed that >75% cTn was exchanged. Myofilament chemo-
mechanical cross-bridge dynamics were determined as function of [Ca2þ] at
SL=2.2 mm using an enzyme-coupled UV absorbance technique (de Tombe
& Stienen, 1995).Compared to wild-type exchange, cTnI63-193 exchanged fi-
bers displayed ~30% decrease in myofilament Ca2þ sensitivity (EC50). In con-
trast, neither maximal tension development, nor maximal ATPase activity (and
consequently tension-cost), were significant different between the groups, nor
was cooperative thin filament activation (Hill coefficient). We conclude that
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predominantly via decreased myofilament Ca2þ-sensitivity. Our results may
benefit rational drug development aimed to prevent ischemic/reperfusion injury
in patients.
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TnI Switch Peptide Position within Cardiac Troponin as Studied by cw-
Epr and DEER
Jean Chamoun1,2, James A. Cooke2, Louise J. Brown2, Peter G. Fajer1.
1FSU, Tallahassee, FL, USA, 2Macquarie University, Sydney, Australia.
Muscle contraction is regulated by the troponin complex which is a heterotrimer
protein consisting of a Ca2þ binding subunit (TnC), an inhibitory subunit (TnI)
and a Tropomyosin binding subunit (TnT). Calcium binding to TnC (‘ON’
state) initiates a series of structural changes in the thin filament proteins leading
to muscle contraction. In the low Ca2þ ‘OFF’ state, the TnI subunit induces
muscle inhibition through its two actin binding domains (residues 133-148
and 166-210). Another region of TnI termed the ‘switch peptide’ (residues
150-161) is essential for a complete relieve of muscle inhibition in the ON state.
The position of the switch peptide is vital since it affects the whereabouts of
both TnI actin binding domains. In theþCa2þ cardiac Tn core crystal structure,
the switch peptide is depicted to be close to the N-lobe of TnC (Takeda et al.,
Nature, 2003) but no or limited knowledge is known about its position in the
absence of Ca2þ. We studied the proximity of the switch peptide to two do-
mains within Tn in both the ‘ON’ and ‘OFF’ states. Two intermolecular dis-
tances from each end of the switch peptide back to the N-lobe of TnC
(TnI152/TnC35, TnI152/TnC84, TnI160/TnC55) and one intramolecular dis-
tance (TnI129/TnI160) within TnI were measured with Conventional Electron
Paramagnetic Resonance (cw) and Double Electron Electron Resonance
(DEER) methods. In the ‘ON’ state, both the intramolecular and intermolecular
distances were less than 2.5nm with narrow distance distributions indicative of
restricted movement. Upon removal of Ca2þ, distances increased considerably
(TnI129/160 to 5nm and TnI151/TnC35 to 3.3nm) with an accompanying in-
crease in the distance distributions suggesting a more flexible, non-bound,
switch peptide.
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Molecular Function of the C-terminal Domain of Cardiac Troponin I
Danamarie Moonoo1, Nancy L. Meyer2, Vanessa Inchausti1, Nicolas
M. Brunet3, Vincent LaBarbera2, P. Bryant Chase2, Brenda Schoffstall1.
1Barry University, Miami Shores, FL, USA, 2Florida State University,
Tallahassee, FL, USA, 3Donders Institute for Brain, Cognition and
Behaviour, Radboud University, Nijmegen, Netherlands.
Ca2þ regulation of cardiac muscle contraction is dependent upon regulation by
tropomyosin (Tm) and troponin (Tn); the extreme C-terminus of the inhibitory
subunit of Troponin (cTnI) binds to actin at low [Ca2þ] and is presumed to hold
Tm in a closed position preventing actomyosin interaction. cTnI’s C terminus
(‘‘mobile domain’’ (MD)) is the site of several human mutations that lead to
familial hypertrophic cardiomyopathy (FHC), therefore it is of interest to clar-
ify the specific function and importance of this domain in cardiac muscle con-
traction. We have demonstrated that even in the absence of Tm, Tn is able to
enhance thin filament sliding speed and heavy meromyosin ATPase activity.
To explore the possibility that the MD plays a role in enhancement of myosin ac-
tivity in cardiac muscle, we have utilized an all-cardiac protein (porcine cardiac
actin and myosin, recombinant human cardiac Tm-Tn) In Vitro Motility assay to
detect alterations in Ca2þ regulation of cardiac actomyosin interaction in the
presence of two specific human recombinant cTn MD structural mutants.
‘‘K164D’’ is truncated after cTnI K164 and ‘‘LINK 2c2’’ has an inserted 8-amino
acid linker before cTnI K164. At pCa5, K164D showed no significant difference
from WT in filament sliding speed at most Tn-Tm concentrations tested, while
sliding speed with LINK 2c2 was significantly slower than WT. Conversely,
at pCa9, K164D was unable to stop actomyosin interaction, with sliding speeds
significantly faster than WT; LINK 2c2 regulated the same as WT at pCa9 for
most concentrations tested. Our in vitro cardiac muscle experimental data sug-
gest that (1) the MD of TnI is a key player in Ca2þ regulation of cardiac muscle
contraction, and (2) the C-terminal Mobile Domain of cTnI is not responsible for
observed functional enhancement of myosin at saturating [Ca2þ].
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Effect of Hypertrophic Cardiomyopathy Associated Troponin I Mutations
on thin Filament Dynamics
Sameeh A. Al-Sarayreh, Mohammed El-Mezgueldi.
University of Leicester, Leicester, United Kingdom.
Troponin I plays an essential role in the regulation of cardiac muscle contrac-
tion. Together with troponin C and T, troponin I induces Ca2þ dependent co-
operative transitions of thin filaments between a blocked, a closed and an
open state. 29 mutations were found in cardiac troponin I in families withhypertrophic cardiomyopathy. Although unknown, the mechanism of molecu-
lar dysfunction is likely to involve an aberrant thin filament responsiveness to
changes in intracellular level of Ca2þ. Our hypothesis is that these mutations
modify important parameters in the cooperative-allosteric transitions of thin fil-
aments. Here we aimed at using transient kinetics to assess the effect of hyper-
trophic cardiomyopathy TnI mutations (Q130R, R145G, and A157V) on the
rate and equilibria of thin filament switching between the blocked, closed
and open states. We found that TnIQ130R and TnIA157V did not affect the
equilibrium constant between the blocked and the closed states (KB). In con-
trast TnIR145G substantially increased KB in the absence of Ca
2þ. An increase
in KB is likely to lead to incomplete relaxation. We also investigated the effect
of these mutations on the cooperative behaviour of thin filaments. TnIQ130R
and A157V did not affect the size of the cooperative unit n while TnIR145G
decrease n value to less than 7. Calcium binding to thin filaments was moni-
tored by change in the fluorescence of IAANS-TnCC84S. Thin filaments recon-
stituted with TnI mutations showed a change in calcium affinity and the rate of
Ca2þ dissociation. These findings suggest that mutations in different regions of
troponin I are likely to have different biochemical effect highlighting the
unique molecular mechanism for each of these mutations.
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N-Terminal Truncated Cardiac TnI Extends Frank-Starling Response of
the Heart
Hanzhong Feng1, X.-P. Huang2, J.-P. Jin1.
1Physiology Department, Wayne State University, Detroit, MI, USA,
2Department of Biomedical Sciences, Florida Atlantic University, Boca
Raton, FL, USA.
Cardiac TnI (cTnI) has a unique N-terminal extension containing the PKA
phosphorylation sites, and its removal by restricted proteolysis in cardiac adap-
tations to hemodynamic stress and b-adrenergic deficiency provides a func-
tional compensation via improving myocardial relaxation (Barbato et al.,
JBC 2005; Feng et al., JBC 2008). By transgenic expression of N-terminal trun-
cated cTnI (cTnI-ND) in the cardiac muscle of cTnI knockout mice, we exam-
ined the function of hearts containing purely cTnI-ND. Working hearts from
the double transgenic mice showed no hypertrophy and normal baseline func-
tion as compared with the wild type controls, confirming the non-destructive
nature of cTnI-ND. When preload was raised to examine the Frank-Starling re-
sponse, left ventricular relaxation velocity was better maintained in cTnI-ND
hearts than that in wild type controls. The effect of cTnI-ND on enhancing re-
laxation resulted in lower left ventricular end diastolic pressure and maintained
left ventricular contractile velocity and end systolic pressure, especially at high
preloads. The overall outcome was larger stroke volumes from cTnI-ND hearts
at increased preloads than the responses of wild type hearts. The enhanced
range and extent of positive response of cTnI-ND hearts to preload demon-
strates that the removal of cTnI N-terminal extension by restricted proteolysis
provides a novel mechanism to maximize the Frank-Starling effect in cardiac
adaptation against hemodynamic and inotropic stresses.
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Functional Effects of Two Troponin I Mutations Linked to Restrictive
Cardiomyopathy
Shannamar Dewey1, Josephine Chen1, Susan Nguyen2, Qian Xu1,
Aldrin v. Gomes1.
1University California, Davis, Davis, CA, USA, 2University California,
Davis, Davis, CA, USA.
Mutations in cardiac troponin, a protein complex that regulates muscle contrac-
tion, have been shown to be linked to cardiomyopathies, which commonly lead
to chest pains, myocardial infarction, or sudden cardiac death. The troponin
complex consists of three proteins: Troponin T, Troponin I (TnI), and Troponin
C (TnC). In recent clinical studies, two novel mutations in cardiac TnI were dis-
covered co-segregated with cardiomyopathy, but their specific functional ef-
fects remain unknown. These mutations are the first frameshift mutations in
cTnI known to be linked to restrictive cardiomyopathy (RCM). The deletion
of two adenines at codon 177 (Delbp529AA) in cardiac TnI, was discovered
in a six year old female RCM patient. The second cTnI mutation included in
this investigation was the result of a deleted guanine in codon 168 which caused
a frame shift and premature stop codon at 176 (DelG502). cTnI DelG502 was
associated with sudden cardiac death. It was found during column purification
that the 34 residue truncation of cTnI removed or greatly decreased its binding
affinity for TnC. However, the Delbp529AA mutant protein, containing 32 al-
ternate C-terminal residues, was successfully purified and formed a functional
troponin complex. Actomyosin ATPase assays demonstrated similar maximal
ATPase activity for complexes containing TNNI3 Delbp529AA compared to
wild type complexes. cTnI Delbp529AA showed increased calcium sensitivity
of ATPase and less inhibitory function compared to wild-type cTnI. Calpain
